Compared to the control group , the treatment group had significantly fewer days of mastalgia ( P < 0.01 ) , a significantly lower severe pain score ( P < 0.01 ) , and significantly less subjective pain and tenderness ( P < 0.05 and P < 0.01 , respectively ) .